A review of the evidence on the effectiveness of children's vision screening

M Mathers1, M Keyes, M Wright

  • 1Centre for Community Health, Royal Children's Hospital Murdoch Childrens Research Institute, and Western Health, Melbourne, Vic, Australia. megan.mathers@mcri.edu.au

Insights

Children's vision screening, particularly between 18 months and 5 years, can improve visual outcomes and educational attainment. However, evidence quality is low, and cost-effectiveness requires further study on quality of life impacts.

Area of Science:

  • Ophthalmology
  • Public Health
  • Pediatrics

Background:

  • Early identification of health conditions through screening programs is crucial for timely interventions.
  • Childhood vision impairment can impact development and educational outcomes.
  • Existing vision screening programs for children vary widely in their components and effectiveness.

Purpose of the Study:

  • To evaluate the effectiveness of children's vision screening programs.
  • To determine the optimal age for vision screening in children.
  • To identify the most effective components of vision screening programs.

Main Methods:

  • A comprehensive literature review was conducted on vision screening programs for children aged 0-16 years.
  • Studies were identified through clinical databases, hand searches, and expert consultations.
  • Methodological quality was assessed using National Health and Medical Research Council (NHMRC) guidelines.

Main Results:

  • Screening children aged 18 months to 5 years, followed by early treatment, improved visual acuity, primarily for amblyopia.
  • Evidence suggests screening is most beneficial during the preschool years.
  • Orthoptists were preferred screening personnel, but trained nurses also demonstrated high sensitivity and specificity.

Conclusions:

  • Childhood vision screening appears beneficial, particularly for treating amblyopia and uncorrected refractive errors, potentially improving educational outcomes.
  • The overall quality of evidence is low, and the cost-effectiveness is questionable without considering quality of life impacts.
  • Further research is needed on neonatal screening effectiveness, quality of life improvements, and economic benefits to optimize programs.

Related Concept Videos